Clinical Study Of Schizophrenia in Both Men and Women

PHASE3CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

January 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

lamotrigine

Trial Locations (32)

10962

GSK Investigational Site, Orangeburg

14620

GSK Investigational Site, Rochester

19401

GSK Investigational Site, Norristown

20852

GSK Investigational Site, Rockville

21061

GSK Investigational Site, Glen Burnie

27509

GSK Investigational Site, Butner

27603

GSK Investigational Site, Raleigh

27609

GSK Investigational Site, Raleigh

28211

GSK Investigational Site, Charlotte

32751

GSK Investigational Site, Maitland

33161

GSK Investigational Site, North Miami

44106

GSK Investigational Site, Cleveland

44122

GSK Investigational Site, Beachwood

44124

GSK Investigational Site, Lyndhurst

53226

GSK Investigational Site, Milwaukee

62040

GSK Investigational Site, Granite City

72201

GSK Investigational Site, Little Rock

75115

GSK Investigational Site, DeSoto

77401

GSK Investigational Site, Bellaire

78756

GSK Investigational Site, Austin

84047

GSK Investigational Site, Midvale

89512

GSK Investigational Site, Reno

91770

GSK Investigational Site, Rosemead

91942

GSK Investigational Site, La Mesa

91950

GSK Investigational Site, National City

92056

GSK Investigational Site, Oceanside

92126

GSK Investigational Site, San Diego

92845

GSK Investigational Site, Garden Grove

06106

GSK Investigational Site, Hartford

02114

GSK Investigational Site, Boston

08021

GSK Investigational Site, Clementon

07033

GSK Investigational Site, Kenilworth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY